🕵️ DBV Technologies S.A. ($DBVT)
SEC insider & ownership activity, last 12 months · CIK 1613780 · every row links its SEC filing
Over the last 12 months insiders sold $15.5M with no open-market buying against it. Epic Bpifrance sold $15.5M in discretionary trades (Dec). Baker BROS. Advisors LP trimmed 17.1% → 10.0%; Baker BROS. Advisors (GP) LLC trimmed 17.1% → 10.0%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $15.5M (7 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Epic Bpifrance | 0 | – | 3 | $15.5M | Dec 18, 2025 |
| Mohideen Pharis | 0 | – | 4 | $27K | Jan 29, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Baker BROS. Advisors LP | 10.0% | 13D | Jan 12, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 10.0% | 13D | Jan 12, 2026 | filing ↗ | |
| Julian C. Baker | 10.0% | 13D | Jan 12, 2026 | filing ↗ | |
| Felix J. Baker | 10.0% | 13D | Jan 12, 2026 | filing ↗ | |
| Suvretta Capital Management, LLC | 9.9% | 13G | Apr 11, 2025 | filing ↗ | |
| Aaron Cowen | 9.9% | 13G | Apr 11, 2025 | filing ↗ | |
| Averill Master Fund, Ltd. | 8.8% | 13G | Apr 11, 2025 | filing ↗ | |
| MPM Bioimpact LLC | 8.8% | 13G | May 15, 2026 | filing ↗ | |
| Janus Henderson Group PLC | 8.8% | 13G | Jan 8, 2026 | filing ↗ | |
| Adage Capital Management, L.P. | 7.3% | 13G | May 13, 2026 | filing ↗ | |
| Robert Atchinson | 7.3% | 13G | May 13, 2026 | filing ↗ | |
| Phillip Gross | 7.3% | 13G | May 13, 2026 | filing ↗ | |
| Raymond Debbane | 6.5% | 13G | May 5, 2026 | filing ↗ | |
| Invus Public Equities, L.P. | 6.1% | 13G | May 5, 2026 | filing ↗ | |
| Invus Public Equities Advisors, LLC | 6.1% | 13G | May 5, 2026 | filing ↗ | |
| Invus Global Management, LLC | 6.1% | 13G | May 5, 2026 | filing ↗ | |
| Siren, L.L.C. | 6.1% | 13G | May 5, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Other events (8.01) | Feb 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 28, 2026 | filing ↗ |
| Other events (8.01) | Jan 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 16, 2026 | filing ↗ |
| Other events (8.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 30, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Earnings (2.02) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 18, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 18, 2025 | filing ↗ |
| Other events (8.01) | Sep 5, 2025 | filing ↗ |